Depression: Psilocybin etwas besser als Escitalopram
Zeitschrift für Phytotherapie August 1, 2022 DOI: 10.1055/a-1857-9047 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 59 |
| Population | Adults with moderate-to-severe major depressive disorder |
| Interventions | Psilocybin Escitalopram |
| Duration | 6-week intervention |
| Topics | Anxiety Psilocybin Depression |
| Keywords | Escitalopram Psychoanalysis Hallucinogen Antidepressant |
| Key findings | Psilocybin therapy was associated with greater reductions in depressive symptoms than escitalopram at 6 weeks, as measured by the QIDS-SR-16. |
Abstract
Carhart-Harris R, Giribaldi B, Nutt DJ et al. Trial of psilocybin versus escitalopram for depression. N Engl J Med 2021; 384: 1402–1411. doi:10.1056/ NEJMoa2032994